Obesity is a disease that shares several characteristics with cancer, but does not get the same society-wide recognition of its disease status, so people with obesity are less likely to get treatment.
Academic rigour, journalistic flair
Articles on Diabetes
Displaying 1 - 20 of 364 articles
People who developed diabetes, psychosis and congestive heart failure, in that order, experienced the largest reduction in life expectancy
The messaging around Ozempic being a miracle cure is not only a lie, it has kicked up a new level of fatphobia.
About one in six pregnant women in Australia are now diagnosed with gestational diabetes. Rates have more than doubled since the thresholds for diagnosis were changed.
Many heat-related health problems can be avoided by adopting a healthy, active lifestyle. But the younger generation is less active than previous generations, and therefore more vulnerable.
Diabetes rates worldwide have been rising steadily since the early 1990s when these data were first estimated. This trend is only going up.
A recent study found that among people who were overweight or obese, taking metformin during a COVID infection reduced the risk of developing long COVID by 40%.
Overreliance on BMI as a measure of weight and health has deepened inequities and led to inaccuracies and overgeneralizations.
As the use of Ozempic, a drug for diabetes, slams into the mainstream as a weight-loss method, will the drug’s use impact our concept of fatness? And how does fatness intersect with race and class?
Influencers have been enthusiastically claiming its success in helping them lose weight, with their posts viewed by millions. You might be surprised what the evidence shows.
In a controversial move in 2021, drug-funding agency Pharmac fully subsidised new diabetes drugs for Māori and Pacific patients. Could the result help set a precedent?
Ozempic uses semaglutide to mimic the role of a hormone naturally produced by the body to create feelings of fullness. Certain foods can do the same thing.
Nine in ten of all deaths in New Zealand are caused by non-communicable diseases such as heart disease and diabetes. Better use of research evidence could save lives and healthcare dollars.
The drugmaker’s move responded to the growing competition that has shaken up the insulin market in recent years.
For parents, encouraging healthy family diets for children from the time they are babies is one way to keep children’s blood sugar levels in check. The Indonesian government can do more to help too.
As tempting as it is, it is not possible to “supplement” oneself out of a bad lifestyle.
Scientists are figuring out why so many diseases and conditions, including diabetes, inflammation and parasitic infection, can affect our eye health. But there are ways to protect your macula.
You’ve probably heard of the drug semaglutide or Ozempic, the diabetes medication being used for weight loss. So what are the risks and benefits? And who should have access to it?
The risk of developing eye complications is high in young people with Type 2 diabetes, which is increasingly affecting children and adolescents, especially those who are more sedentary.
Shift work throws our circadian rhythm out of whack, which can impact the major systems in our bodies.
Top contributors
-
Professor (Hon) at Monash University, Baker Heart and Diabetes Institute
-
Professor of Medicine, Monash University
-
Associate Professor and Director of Evidence-Based Healthcare DPhil Programme, University of Oxford
-
General Manager Diabetes Services, Baker Heart and Diabetes Institute
-
Laureate Professor in Nutrition and Dietetics, University of Newcastle
-
Professor of Public Health Policy, Deakin University
-
Professor and Programme Director, SA MRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand
-
Senior researcher, University of the Witwatersrand
-
Project Manager, University of Pretoria Diabetes Research Centre, University of Pretoria
-
Assistant Professor, Bond University
-
Clinical Endocrinologist & Associate Lecturer, University of the Witwatersrand
-
Professor of Physical Activity, Lifestyle, and Population Health, University of Sydney
-
Professor of Global Health, Institute for Applied Research, University of Birmingham
-
Professor of Health Sciences, Simon Fraser University
-
Assistant Professor, Critical Disability Studies, Carleton University
